Grafa News and Videos — Page 140

State Street Corporation (NYSE:STT) reported third-quarter 2026 financial results, with adjusted earnings per share of $3.69, beating analyst expectations of $3.67.

Entrada Therapeutics (NASDAQ:TRDA) announced initial results from the first cohort of its Phase 1/2 ELEVATE-45-201 study evaluating ENTR-601-45 in patients with Duchenne muscular dystrophy.

Eton Pharmaceuticals (NASDAQ:ETON) announced exclusive U.S. licensing and supply agreements with Aquestive Therapeutics (NASDAQ:AQST) for LIBERVANT, a seizure-cluster treatment.

Sono-Tek (NASDAQ:SOTK) reported fiscal first-half 2027 financial results, with revenue increasing 6% year over year to $10.893 million.

Fastenal (NASDAQ:FAST) reported third-quarter 2026 financial results, delivering higher-than-expected revenue and earnings.

Bank of America (NYSE:BAC) reported third-quarter 2026 financial results with adjusted earnings per share of $1.08, compared with analyst expectations of $1.10.

National Fuel Gas (NYSE:NFG) announced that its board of directors approved a plan to spin off its Integrated Upstream and Gathering (IUG) business into a separate public company.

Quoin Pharmaceuticals (NASDAQ:QNRX) announced that the European Medicines Agency has granted orphan drug designation to QRX003 for the treatment of Peeling Skin Syndrome, a rare genetic skin disorder.

Ocugen (NASDAQ:OCGN) entered an agreement granting Roots Pharmaceutical exclusive regional rights to OCU400, an investigational gene therapy for retinitis pigmentosa, an inherited vision-loss disease.

BlackRock (NYSE:BLK) reported third-quarter 2026 financial results with revenue of $7.8 billion, representing a 19% increase compared with the same period last year.